Alexander Chehrazi-Raffle

18PUBLICATIONS

70CO-AUTHORS

Neurology and neuromuscular diseasesMolecular targetsPredictive and prognostic markersMedical and health lawCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Jun 12, 2026

Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial Availability.

|May 18, 2026

Use of ALK Inhibitors in Patients With Nonlung Malignancies Bearing <i>ALK</i> Alteration Prolongs Treatment Duration.

|Mar 28, 2026

Disparities in Outcomes in Latino Subpopulations with Localized Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Analysis.

Salvador Jaime-Casas, Regina Barragan-Carrillo, Anjaney Kothari

|Jan 08, 2026

Olaparib Response in a Patient With Platinum-Refractory Germ Cell Tumor Harboring a Somatic <i>BRIP1</i> Mutation.

Camila Bobato Lara Gismondi, Ruchi Agarwal, Maria Fernanda Botelho Teixeira

|Oct 16, 2025

Clinical Predictors and Prognostic Significance of Pathologic Disease Upstaging at Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer.

Salvador Jaime-Casas, Wesley Yip, Daniel J Lama

|Sep 24, 2025

Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.

Rebecca Hassoun, Reuben Ben-David, John P Sfakianos

Pageof 3

Frequent Collaborators

Benjamin Mercier

Daniela V Castro

Sumanta Pal

Nazli Dizman

Miguel Zugman

Hedyeh Ebrahimi

Tanya Dorff

Salvador Jaime-Casas

Vitor Góes

Zeynep Zengin

Frequent Collaborators

Benjamin Mercier

Daniela V Castro

Sumanta Pal

Nazli Dizman